Skip to content

Effectiveness of Local Application of Warm Air in Patients With Common Cold (HELI Study)

Effectiveness of Local Application of Warm Air in Patients With Common Cold (HELI Study)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00552981
Acronym
HELI
Enrollment
157
Registered
2007-11-02
Start date
2007-11-30
Completion date
2009-04-30
Last updated
2012-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Common Cold

Keywords

common cold, Finnish sauna, rct

Brief summary

In a randomized controlled trial, the investigators include patients with beginning symptoms of a common cold and compare two interventions: 1. the inhalation of warm air for inducing a warming of the throat and 2. the inhalation of ambient air as control. As outcome the effect on symptoms and duration of the common cold will be assessed. The interventions will consist of visits with a duration of 2-3 minutes on three following days in a Finnish sauna. Patients will be fully dressed.

Interventions

PROCEDUREinhalation of warm air in a Finnish sauna

three times on three following days, each 2-3 minutes

PROCEDUREinhalation of ambient air in a Finnish sauna

three times on three following days, each 2-3 minutes

Sponsors

Karl and Veronica Carstens Foundation
CollaboratorOTHER
Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* symptom duration between 2 and 24 hours * at least two of the ten following symptoms: cough, headache, hoarseness, muscle ache, nasal drainage, nasal congestion, scratchy throat, sore throat, sneezing, and fever * no usage of medication bought in a pharmacy * informed consent

Exclusion criteria

* fever \>38.5°C * systolic blood pressure below 100 mmHg or above 160 mmHg * severe chronic disease, which makes study participation impossible * pregnancy

Design outcomes

Primary

MeasureTime frame
Symptom Score for Common ColdArea under the curve day 2 to 7

Secondary

MeasureTime frame
Usage of medication against common coldDay 1 to 7
generalized feeling ill on a numeric rating scale 0-10,Day 1, 2, 3, 5 and 7
safety (adverse events and serious adverse events)1 to 7 days

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 30, 2026